More articles from Editorials

Airway clearance technique in the modern era of bronchiectasis management
Cui-Xia Pan, Ming-Xin Shi, Wei-Jie Guan

ERJ Open Research Mar 2023, 9 (2) 00674-2022; DOI: 10.1183/23120541.00674-2022
Triple therapy in COPD: understanding the data
Samy Suissa

ERJ Open Research Jan 2023, 9 (1) 00615-2022; DOI: 10.1183/23120541.00615-2022
Dyspnoea in COVID-19 recovery beyond the intensive care unit: the potential impact of inspiratory muscle weakness
Bernie Bissett

ERJ Open Research Jan 2023, 9 (1) 00521-2022; DOI: 10.1183/23120541.00521-2022
When more is more: the role of additional upfront therapy in pulmonary arterial hypertension
Shannon Niedermeyer, Paul Hassoun

ERJ Open Research Jan 2023, 9 (1) 00592-2022; DOI: 10.1183/23120541.00592-2022
ERJ Open Research receives its first impact factor and plans for the next step
Woo-Jung Song, Esther Barreiro

ERJ Open Research Jan 2023, 9 (1) 00608-2022; DOI: 10.1183/23120541.00608-2022
Airway disease: a confusion inside an enigma
Alyn H. Morice

ERJ Open Research Oct 2022, 8 (4) 00519-2022; DOI: 10.1183/23120541.00519-2022
Multidrug-resistant tuberculosis: diagnosis, checklists, adverse events, advice and outcomes
Graham H. Bothamley

ERJ Open Research Oct 2022, 8 (4) 00512-2022; DOI: 10.1183/23120541.00512-2022
Dual CFTR modulator therapy efficacy in the real world: lessons for the future
Anna-Maria Dittrich, Sandra Y. Chuang

ERJ Open Research Oct 2022, 8 (4) 00464-2022; DOI: 10.1183/23120541.00464-2022
Complex pathways leading to future paediatric asthma exacerbations
Amrita Dosanjh

ERJ Open Research Oct 2022, 8 (4) 00322-2022; DOI: 10.1183/23120541.00322-2022
It is time to end our love affair with short-acting β₂-agonists in asthma
Michael G. Crooks, Shoaib Faruqi

ERJ Open Research Oct 2022, 8 (4) 00353-2022; DOI: 10.1183/23120541.00353-2022

Main menu

User menu

Search

More articles from Editorials

Pages

Contact us